|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
WO1996026190A1
(en)
|
1995-02-22 |
1996-08-29 |
Smithkline Beecham Corporation |
Integrin receptor antagonists
|
|
IL123164A
(en)
|
1995-08-30 |
2001-03-19 |
Searle & Co |
Meta-guanidine urea thiourea or azacyclic amino benzoic acid derivatives and pharmaceutical compositions containing them
|
|
CZ203898A3
(cs)
|
1995-12-29 |
1999-03-17 |
Smithkline Beecham Corporation |
Antagonista vitronektinového receptoru, farmaceutický přípravek s jeho obsahem, způsob a použití
|
|
WO1997024122A1
(en)
|
1995-12-29 |
1997-07-10 |
Smithkline Beecham Corporation |
Vitronectin receptor antagonists
|
|
UA60311C2
(uk)
|
1996-10-02 |
2003-10-15 |
Смітклайн Бічам Корпорейшн |
Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
|
|
US5942492A
(en)
|
1996-11-12 |
1999-08-24 |
Angstrom Pharmaceuticals, Inc. |
Cyclic peptides that bind to urokinase-type plasminogen activator receptor
|
|
US6794358B1
(en)
|
1997-03-28 |
2004-09-21 |
Brigham And Women's Hospital |
Peptide ligands of the urokinase receptor
|
|
EP1000031A4
(en)
|
1997-07-25 |
2001-08-16 |
Smithkline Beecham Corp |
VITRONECTIN RECEPTOR ANTAGONISTS
|
|
AU8689798A
(en)
|
1997-08-04 |
1999-02-22 |
Smithkline Beecham Corporation |
Integrin receptor antagonists
|
|
BR9907218A
(pt)
|
1998-01-23 |
2000-10-24 |
Merck Patent Gmbh |
Anticorpo monoclonal anti alfav-integrina e seu uso para inibir a fixação de alfav-beta6-integrina à fibronectina
|
|
US6852318B1
(en)
|
1998-05-08 |
2005-02-08 |
The Regents Of The University Of California |
Methods for detecting and inhibiting angiogenesis
|
|
US6492325B1
(en)
|
1998-05-22 |
2002-12-10 |
Boys Town National Research Hospital |
Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease
|
|
IT1299575B1
(it)
|
1998-07-23 |
2000-03-16 |
Demetrio Biancucci |
Suola per calzatura provvista di rampini o mezzi chiodati in grado di passare da una posizione a contatto con il suolo ad una posizione
|
|
EP0982036A1
(en)
|
1998-08-28 |
2000-03-01 |
Wilex Biotechnology GmbH |
Modulation of Beta2 -integrin-mediated cell adhesion
|
|
US6451972B1
(en)
|
1998-11-16 |
2002-09-17 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
|
|
PL350057A1
(en)
|
1999-02-20 |
2002-11-04 |
Merck Patent Gmbh |
β-ALANINE DERIVATIVES
|
|
ES2274781T3
(es)
|
1999-04-13 |
2007-06-01 |
Wilex Ag |
Empleo diagnostico y terapeutico de anticuerpos contra el receptor de la urocinasa.
|
|
CN1589145A
(zh)
|
1999-06-02 |
2005-03-02 |
麦克公司 |
αv整联蛋白受体拮抗剂
|
|
WO2001017544A1
(en)
|
1999-09-03 |
2001-03-15 |
The Brigham And Women's Hospital, Inc. |
Peptides that bind to urokinase receptor
|
|
SI1214091T1
(sl)
|
1999-09-14 |
2006-10-31 |
Biogen Idec Inc |
Terapija za kronicno ledvicno odpoved z uporabo enega ali vec integrinskih antagonistov
|
|
US6955808B2
(en)
|
1999-09-24 |
2005-10-18 |
Uab Research Foundation |
Capsid-modified recombinant adenovirus and methods of use
|
|
DE10028575A1
(de)
|
2000-06-14 |
2002-03-14 |
Basf Ag |
Integrinliganden
|
|
GB9928882D0
(en)
|
1999-12-08 |
2000-02-02 |
Zeneca Ltd |
Assay method
|
|
US6825167B1
(en)
|
2000-04-03 |
2004-11-30 |
Regents Of The University Of Minnesota |
Genetic modification of endostatin
|
|
GB0011817D0
(en)
|
2000-05-16 |
2000-07-05 |
Pharmacia & Upjohn Spa |
Antagonists of integrin receptors
|
|
AU2001269821A1
(en)
|
2000-06-15 |
2001-12-24 |
Barbara Chen |
Cycloalkyl alkanoic acids as integrin receptor antagonists
|
|
WO2001096310A1
(en)
|
2000-06-15 |
2001-12-20 |
Pharmacia Corporation |
Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
|
|
US6649597B1
(en)
|
2000-06-22 |
2003-11-18 |
The University Of Iowa Research Foundation |
Targeting vector to the urokinase plasminogen activator receptor
|
|
GB0016791D0
(en)
|
2000-07-07 |
2000-08-30 |
Novartis Ag |
Organic compounds
|
|
US7163681B2
(en)
*
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
JP2004521079A
(ja)
|
2000-08-29 |
2004-07-15 |
ファルマシア・コーポレーション |
アルファーｖベータ３アンタゴニストとして有用な二環式環系を含有する化合物
|
|
US6531494B1
(en)
|
2001-08-29 |
2003-03-11 |
Pharmacia Corporation |
Gem-substituted αvβ3 antagonists
|
|
US6720327B2
(en)
|
2000-09-27 |
2004-04-13 |
Pharmacia Corporation |
Lactone integrin antagonists
|
|
US20020072500A1
(en)
|
2000-09-27 |
2002-06-13 |
Thomas Rogers |
Hydroxy acid integrin antagonists
|
|
EP1197553A1
(en)
|
2000-10-12 |
2002-04-17 |
A3D GmbH, Antisense Design & Drug Development |
Antisense nucleic acid against alphaV integrin
|
|
DE10112771A1
(de)
|
2001-03-16 |
2002-09-26 |
Merck Patent Gmbh |
Inhibitoren des Integrins alpha¶v¶beta¶6¶
|
|
US6794385B2
(en)
|
2001-08-08 |
2004-09-21 |
Pharmacia & Upjohn, S.P.A. |
Benzoxazine derivatives useful as integrin receptor antagonists
|
|
DE10204789A1
(de)
*
|
2002-02-06 |
2003-08-14 |
Merck Patent Gmbh |
Inhibitoren des Integrins alpha¶v¶beta6
|
|
US7138230B2
(en)
|
2002-12-06 |
2006-11-21 |
Renovar, Inc. |
Systems and methods for characterizing kidney diseases
|
|
ITRM20020402A1
(it)
|
2002-07-29 |
2004-01-29 |
Sigma Tau Ind Farmaceuti |
Derivati fluoro-alchil-ciclopeptidi ad attivita' anti-integrine.
|
|
AU2003259891A1
(en)
*
|
2002-08-16 |
2004-03-19 |
Janssen Pharmaceutica N.V. |
Piperidinyl compounds that selectively bind integrins
|
|
EP1592421A1
(en)
|
2002-12-20 |
2005-11-09 |
Pharmacia Corporation |
Heteroarylalkanoic acids as integrin receptor antagonists
|
|
JP2006514050A
(ja)
|
2002-12-20 |
2006-04-27 |
ファルマシア・コーポレーション |
インテグリン受容体アンタゴニスト誘導体としてのβ−アミノ酸化合物のＲ異性体
|
|
DE502004007051D1
(de)
|
2003-02-06 |
2008-06-19 |
Merck Patent Gmbh |
Peptidische sulfonamide
|
|
WO2004090108A2
(en)
|
2003-04-03 |
2004-10-21 |
Alnylam Pharmaceuticals |
Irna conjugates
|
|
KR100568755B1
(ko)
|
2003-04-03 |
2006-04-07 |
주식회사 리젠 바이오텍 |
Ｙｈ 모티프를 포함하는 펩타이드를 유효성분으로함유하는 혈관신생 억제제
|
|
US7560244B2
(en)
*
|
2003-06-04 |
2009-07-14 |
Joslin Diabetes Center, Inc. |
Method of evaluating a subject for risk or predisposition of reduced renal function over time
|
|
US7365154B2
(en)
|
2003-06-23 |
2008-04-29 |
Centocor, Inc. |
Peptides antagonistic to an anti-angiogenic antibody and uses therefor
|
|
ITMI20031476A1
(it)
|
2003-07-18 |
2005-01-19 |
Univ Degli Studi Milano |
Composti peptido-mimetici a struttura azabicicloalcanica comprendenti la sequenza rgd
|
|
US8187595B2
(en)
|
2004-05-07 |
2012-05-29 |
The University Of North Carolina At Chapel Hill |
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I
|
|
EP1755660B1
(en)
*
|
2004-05-07 |
2010-03-24 |
The University of North Carolina at Chapel Hill |
Method for enhancing or inhibiting insulin-like growth factor-i
|
|
PT1765397E
(pt)
|
2004-05-25 |
2013-02-04 |
Tactic Pharma Llc |
Anticorpos inibidores que se ligam ao complexo ativador plasminogénico do tipo uroquinasa (upa) e seu receptor (upar)
|
|
JP2008516947A
(ja)
|
2004-10-14 |
2008-05-22 |
ファルマシア コーポレーション |
ビフェニルインテグリンアンタゴニスト
|
|
WO2007056435A2
(en)
|
2005-11-08 |
2007-05-18 |
The General Hospital Corporation |
Dynamin mediated diseases and associated methods and products
|
|
US20070244046A1
(en)
|
2006-03-29 |
2007-10-18 |
Margarita Gutova |
Identification and characterization of cancer stem cells and methods of use
|
|
TW200813091A
(en)
|
2006-04-10 |
2008-03-16 |
Amgen Fremont Inc |
Targeted binding agents directed to uPAR and uses thereof
|
|
US20080020979A1
(en)
*
|
2006-06-09 |
2008-01-24 |
Rapraeger Alan C |
Peptides of Syndecan-1 For Inhibiting Angiogenesis
|
|
US8815519B2
(en)
|
2006-12-22 |
2014-08-26 |
Hvidovre Hospital |
Method for predicting cancer and other diseases
|
|
US20100158858A1
(en)
*
|
2007-04-13 |
2010-06-24 |
Liangxian Cao |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
|
JP2011503531A
(ja)
|
2007-10-26 |
2011-01-27 |
ジェネンテック， インコーポレイテッド |
ウロキナーゼ型プラスミノーゲン活性化因子（ｕＰＡ）活性の阻害
|
|
EP2730282A1
(en)
*
|
2007-11-08 |
2014-05-14 |
The General Hospital Corporation |
Methods and compositions for the treatment of proteinuric diseases
|
|
NZ610239A
(en)
|
2008-04-30 |
2014-11-28 |
Immunogen Inc |
Cross-linkers and their uses
|
|
CA2779958A1
(en)
|
2008-11-06 |
2010-05-14 |
University Of Miami |
Role of soluble upar in the pathogenesis of proteinuric kidney disease
|
|
EP2608804A4
(en)
|
2010-08-27 |
2015-03-11 |
Univ Miami |
TREATMENT OF KIDNEY DISEASES
|
|
CA2882757A1
(en)
*
|
2012-08-31 |
2014-03-06 |
The University Of North Carolina At Chapel Hill |
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (igf-1)
|